VECTURA LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +1.6%

  £25,600,000 → £26,000,000

• Cash

  +38.1%

  £6,300,000 → £8,700,000

• Net assets

  -78.8%

  -£65,200,000 → -£116,600,000

• Employees

  -4%

  352 → 338

• Operating profit

  +7.9%

  -£47,100,000 → -£43,400,000

• Profit before tax

  -35.9%

  -£36,500,000 → -£49,600,000

• Wages

  -4.9%

  £24,400,000 → £23,200,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. VECTURA LIMITED 2004-07-13 → present
2. COORDINATED DRUG DEVELOPMENT LIMITED 1983-02-03 → 2004-07-13

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Grant Thornton

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Consequently, the Directors are confident that the Company will have sufficient funds to continue to meet its liabilities as they fall due for at least twelve months from the date of approval of the financial statements.”

Significant events

• “On 17 September 2024, the Company's ultimate parent, Philip Morris Inc, announced the sale of its investment in Vectura Group Limited and its subsidiaries, including Vectura Limited, to Molex Asia Holdings Limited, a UK incorporated company. The sale was completed on 31 December 2024.”
• “On 25 November 2024, in connection with the change in control discussed above, the Company received a loan in the amount of £67.0m from Vectura Group Limited. The Company used this cash to repay its revolving credit facility with Philip Morris Finance AG, a previous group affiliate prior to the change of control, in full. The amount repaid was £63.5m.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

6

last 12 months

Capital events

0

last 24 months

Officers appointed

2

last 12 months

Officers resigned

2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.